Presentation is loading. Please wait.

Presentation is loading. Please wait.

Laurens W. Wollersheim, MD, Wilson W

Published byEser Şeker Modified over 5 years ago

Similar presentations

Presentation on theme: "Laurens W. Wollersheim, MD, Wilson W"— Presentation transcript:

1 Stentless vs Stented Aortic Valve Bioprostheses in the Small Aortic Root 
Laurens W. Wollersheim, MD, Wilson W. Li, MD, Abdullah Kaya, MD, PhD, Berto J. Bouma, MD, PhD, Antoine H. Driessen, MD, Wim J. van Boven, MD, PhD, Jan van der Meulen, MD, Bas A. de Mol, MD, PhD  Seminars in Thoracic and Cardiovascular Surgery  Volume 28, Issue 2, Pages (June 2016) DOI: /j.semtcvs Copyright © 2016 The Authors Terms and Conditions

2 Figure 1 Survival. (Color version of figure is available online.)
Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2016 The Authors Terms and Conditions

3 Figure 2 Cumulative incidence function estimates of aortic valve reoperation and structural valve deterioration. SVD, structural valve deterioration. (Color version of figure is available online.) Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2016 The Authors Terms and Conditions

4 Figure 3 Mixed effects model of echocardiographic results. MF, Mitroflow; Pmax, maximum valvular gradient; Pmean, mean valvular gradient; SOLO, Freedom SOLO. (Color version of figure is available online.) Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2016 The Authors Terms and Conditions

5 Mixed effects model of echocardiographic results of the peak valvular gradient.
Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2016 The Authors Terms and Conditions

Download ppt "Laurens W. Wollersheim, MD, Wilson W"

Similar presentations

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P
Davide Gabbieri, MD, Pascal M

Davide Gabbieri, MD, Pascal M
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Randomized Trial of Carnitine for the Prevention of Perioperative Atrial Fibrillation  Farzaneh Dastan, Pharm D, Azita Hajhossein Talasaz, Pharm D, BCPS,

Randomized Trial of Carnitine for the Prevention of Perioperative Atrial Fibrillation  Farzaneh Dastan, Pharm D, Azita Hajhossein Talasaz, Pharm D, BCPS,
An unusual case of severe aortic valve stenosis in an adult caused by aortic valve inflammatory myofibroblastic tumor  Dong Zhao, MD, Chunsheng Wang,

An unusual case of severe aortic valve stenosis in an adult caused by aortic valve inflammatory myofibroblastic tumor  Dong Zhao, MD, Chunsheng Wang,
Challenging homografts as the holy grail for aortic valve endocarditis

Challenging homografts as the holy grail for aortic valve endocarditis
Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 
Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,

Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,
Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.
Sergey Leontyev, MD, Michael A

Sergey Leontyev, MD, Michael A
Sreekumar Subramanian, MD, Sergey Leontyev, MD, Michael A

Sreekumar Subramanian, MD, Sergey Leontyev, MD, Michael A
Fate of aortic bioprostheses: An 18-year experience

Fate of aortic bioprostheses: An 18-year experience
Marcel Ricklefs, MD, Jasmin S. Hanke, MD, Günes Dogan, MD, L

Marcel Ricklefs, MD, Jasmin S. Hanke, MD, Günes Dogan, MD, L
Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E

Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E
Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.

Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.
Bigger valve size is not always better

Bigger valve size is not always better
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

Similar presentations

Ads by Google